Clinical trials
Myocardial Infarction trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 3 |
| 2005 | 2 |
| 2006 | 3 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 5 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Recruiting | 6 |
| Active, not recruiting | 5 |
| Terminated | 2 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medical University of Vienna | 6 |
| Novartis Pharmaceuticals | 4 |
| AstraZeneca | 2 |
| Boehringer Ingelheim | 2 |
| Deutsches Herzzentrum Muenchen | 2 |
| Sanofi | 2 |
| University Hospital, Basel, Switzerland | 2 |
| Biotronik SE & Co. KG | 1 |
| CSL Behring | 1 |
| Centocor, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myocardial Infarction | 39 |
| Cardiovascular Diseases | 8 |
| ST Elevation Myocardial Infarction | 7 |
| Stroke | 7 |
| Coronary Artery Disease | 6 |
| Acute Coronary Syndrome | 5 |
| Atherosclerosis | 4 |
| Angina, Unstable | 3 |
| Anterior Wall Myocardial Infarction | 3 |
| Inferior Wall Myocardial Infarction | 3 |
Trials
Showing 26 to 39 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.